Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial
Whilst systemic corticosteroids and conventional immunomodulators have been the primary therapeutic agents, evolving strategies, including biologics and small molecules targeting tumour necrosis factor, different cytokines, or Janus kinase signalling pathways, signify a shift towards a precision management paradigm that considers individual clinical presentations
doi: 10.1210/endrev/bnz002 43 AmbatiSDuanJHartzellDLChoiYHDella-FeraMABaileCA
In other words, a company like Lifevantage can and does claim that its products have been researched at Harvard and other great institutions, but if that research has only been on animals or in a lab, well, Im unimpressed
What is the Trulicity lawsuit about
At that time, Natures Sunshine had no illusions about their brand predicament